Abstract
Rapid rise in childhood obesity prevalence worldwide and its major implications for health warrant the development of better prevention strategies. Here, we analyzed electronic health records of children from Israel’s largest healthcare provider from 2002 to 2018 and developed a model for predicting children’s obesity. Data included demographics, anthropometric measurements, medications, diagnoses, and laboratory tests of children and their families. Obesity was defined as body mass index (BMI) ≥95th percentile for age and sex. To identify the most critical time-window in which the largest annual increases in BMI percentile occurs during early childhood, we first analyzed childhood BMI trajectories among 382,132 adolescents. Next, we devised a prediction model targeted to identify children at high risk of obesity prior to this time-window, predicting obesity at 5-6 years of age based on data from the first 2 years of life of 136,196 children. Retrospective BMI analysis revealed that among obese adolescents, the greatest acceleration in BMI percentiles occured between 2-4 years of age. Our model, validated temporally and geographically, accurately predicted obesity at 5-6 years old (auROC of 0.804). Discrimination results on subpopulations demonstrated its robustness across the pediatric population. The model’s most influential features included anthropometric measurements of the child and family. Other impactful features included ancestry and pregnancy glucose. Antibiotics exposure in utero and during the first 2 years of life had no observed impact on obesity prediction. Our model, targeted to identify children prior to the most critical time-window of BMI acceleration, may allow a more accurate identification and implementation of early prevention strategies for children at high risk of obesity and can be readily embedded into healthcare systems.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Clalit healthcare organization. Experiment protocol number 0195-17-COM2. Experiment topic: Disease prediction models using retrospective data and statistical analysis of electronic health records.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study originates from Clalit healthcare. Restrictions apply to the availability of these data and so are not publicly available. Due to restrictions, it can only be accessed through requests from the authors and/or the Clalit healthcare organization.
